Views for Trial participation disclosure and gel use behavior in the CAPRISA 004 tenofovir gel trial.
Total visits
| views | |
|---|---|
| Trial participation disclosure and gel use behavior in the CAPRISA 004 tenofovir gel trial. | 340 |
Total visits per month
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
File Visits
| views | |
|---|---|
| Succop_Stacey_M_2014.pdf | 188 |
| Succop_Stacey_M_2014.pdf(legacy) | 31 |
Top country views
| views | |
|---|---|
| United States | 137 |
| South Africa | 58 |
| Sweden | 26 |
| Germany | 25 |
| Netherlands | 25 |
| China | 9 |
| Vietnam | 9 |
| Finland | 8 |
| Ireland | 8 |
| Singapore | 5 |
| Russia | 4 |
| Canada | 3 |
| India | 3 |
| South Korea | 2 |
| Turkey | 2 |
| Austria | 1 |
| Brazil | 1 |
| Estonia | 1 |
| Iraq | 1 |
| Moldova | 1 |
| Ukraine | 1 |
Top city views
| views | |
|---|---|
| Ashburn | 65 |
| Johannesburg | 25 |
| Hanoi | 9 |
| Dublin | 8 |
| Des Moines | 7 |
| Washington | 5 |
| Andover | 4 |
| Durban | 4 |
| Bengaluru | 3 |
| Cape Town | 3 |
| Mountain View | 3 |
| Pretoria | 3 |
| Secaucus | 3 |
| Honeydew | 2 |
| Istanbul | 2 |
| Santa Clara | 2 |
| Seattle | 2 |
| Singapore | 2 |
| Tzaneen | 2 |
| Beijing | 1 |
| Brooklyn | 1 |
| Chengdu | 1 |
| Chuzhou | 1 |
| Heidelberg | 1 |
| Nanchang | 1 |
| Phoenix | 1 |
| Stellenbosch | 1 |
| Valencia | 1 |
| Vienna | 1 |